CIK 0001285819
- Non-accelerated filer
- Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911663741
- Phone
- +1 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,837,566
- in 4 filings, $626K under 10b5-1 plans
Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-30 | Kelbon Marcia S. VP Patent and General Counsel | Sale | −35,000 | $24.45 | $856K | 192,645 |
| 2018-08-30 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −35,000 | 7,529 | ||
| 2018-07-27 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +5,723 | $4.10 | $23K | 198,368 |
| 2018-07-27 | Kelbon Marcia S. VP Patent and General Counsel | Sale | −5,723 | $21.73 | $124K | 192,645 |
| 2018-07-27 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −5,723 | 42,529 | ||
| 2018-07-26 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +35,000 | $4.10 | $144K | 219,645 |
| 2018-07-26 | Kelbon Marcia S. VP Patent and General Counsel | Sale | −35,000 | $21.53 | $754K | 184,645 |
| 2018-07-26 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +8,000 | $6.05 | $48K | 192,645 |
| 2018-07-26 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −35,000 | 48,252 | ||
| 2018-07-26 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −8,000 | 61,996 | ||
| 2018-07-12 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion | +4,277 | $4.10 | $18K | 188,922 |
| 2018-07-12 | Kelbon Marcia S. VP Patent and General Counsel | Sale | −4,277 | $21.48 | $92K | 184,645 |
| 2018-07-12 | Kelbon Marcia S. VP Patent and General Counsel | Exercise or conversion · Stock Option (Right to Buy) | −4,277 | 83,252 | ||
| 2018-06-15 | Shah Rajiv Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2018-06-15 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2018-06-15 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2018-06-15 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2018-06-15 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2018-06-15 | Aspiri Ray Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2018-05-15 | JACOBSEN MICHAEL A VP Finance and CAO | Exercise or conversion | +12,812 | $9.37 | $120K | 21,312 |
Page 12 of 20 · 391 trades